Hydrostasis Awarded $225,000 Phase I Grant from SBIR program with the NIH
August 2020

SAN DIEGO, August 2020 -- Hydrostasis, Inc. has been awarded a $225,000 Phase I grant from the SBIR Program with Department of Health and Human Services, National Institutes of Health: National Heart, Lung, and Blood Institute to support a study of a wearable sensor for real-time continuous monitoring of hydration status in older adults with heart failure.

Approximately 6 million Americans are living with heart failure, and over 800,000 additional adults are diagnosed with heart failure each year. Heart failure is a serious but common condition where the heart cannot pump enough blood to meet the body's needs. In people 65 and older, heart failure is also caused by a thickened and stiff heart muscle, causing fluid to back up into the lungs when the heart is stressed. The presence of excess fluid uniformly signals a problem that must be addressed to avoid costly hospitalization and increased mortality. Annual costs in the U.S. associated with heart failure exceed $60 billion.

Hydrostasis Founder & CEO, Debbie Chen, said, “We are excited and thankful for this grant award from National Institutes of Health - National Heart, Lung and Blood Institute. It is a great opportunity for us to continue to develop our solution, expand our testing, and drive our business forward. We are on our fourth iteration of the Hydrostasis hydration monitoring solution and look forward to completing this study for use of our technology to help older adults with heart failure.”  


More information about the NIH grants and funding can be found at: https://grants.nih.gov/grants/oer.htm

More from our blog
A Surreal Moment at CES 2026
CES has a way of compressing years of work into a single moment.
Hydrostasis Heads to CES 2026
Hydrostasis is kicking off the new year at CES 2026
GECA Watch 2.0 Is Live
We just went live with GECA Watch 2.0.
Inside Our IV Hydration Research Study with GECA Watch 2.0
A few weeks ago, we completed a hands-on research study with ASAP IVs, putting GECA Watch 2.0 to the test in a real clinical setting.
Taking GECA Watch 2.0 Into the Real World
This past weekend, we took GECA Watch 2.0 out of the lab and into the real world during a research study hosted at ASAP IVs
A Sneak Peek at GECA Watch 2.0: San Diego Event Recap
This past weekend, we opened the doors in Encinitas for a first look at GECA Watch 2.0, and San Diego showed up.